{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:26:05Z","timestamp":1768710365940,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872733"],"award-info":[{"award-number":["81872733"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803353"],"award-info":[{"award-number":["81803353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bioorg.2019.01.039","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:38:44Z","timestamp":1548121124000},"page":"166-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance"],"prefix":"10.1016","volume":"86","author":[{"given":"Qianqian","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-083X","authenticated-orcid":false,"given":"Jiaqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutta","family":"Kairuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenglong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.01.039_b0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bioorg.2019.01.039_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd4461","article-title":"What do drug transporters really do?","volume":"14","author":"Nigam","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.01.039_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2019.01.039_b0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1098\/rstb.2008.0125","article-title":"Review structure and mechanism of ATP-binding cassette transporters","volume":"364","author":"Locher","year":"2009","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.bioorg.2019.01.039_b0025","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2019.01.039_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2019.01.039_b0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: structure, function and role in chemoresistance","volume":"9","author":"Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bioorg.2019.01.039_b0040","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.039_b0045","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2019.01.039_b0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2019.01.039_b0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0959-8049(96)00091-3","article-title":"Clinical trials of P-glycoprotein reversal in solid tumours","volume":"32A","author":"Ferry","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2019.01.039_b0060","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1158\/0008-5472.CAN-10-0111","article-title":"Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters","volume":"70","author":"Mi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2019.01.039_b0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bcp.2014.06.006","article-title":"Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1","volume":"90","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.01.039_b0070","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1021\/acs.jmedchem.6b01787","article-title":"Design, synthesis, and pharmacological characterization of N-(4-(2 (6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine derivatives: novel inhibitors reversing P-glycoprotein-mediated multidrug resistance","volume":"60","author":"Qiu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.039_b0075","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.bmc.2014.05.013","article-title":"Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors","volume":"22","author":"Liu","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.039_b0080","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/jm201121b","article-title":"Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation","volume":"55","author":"Chan","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.039_b0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1989.306","article-title":"The MTT assay underestimates the growth inhibitory effects of interferons","volume":"60","author":"Jabbar","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2019.01.039_b0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0959-8049(01)00356-2","article-title":"The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7\/adr cells","volume":"38","author":"Fu","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2019.01.039_b0095","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.7314\/APJCP.2013.14.9.4983","article-title":"Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line","volume":"14","author":"Wang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bioorg.2019.01.039_b0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/bjc.1989.252","article-title":"Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia","volume":"60","author":"Sargent","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2019.01.039_b0105","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1021\/jm900194w","article-title":"Modulation of multidrug resistance protein 1 (MRP1\/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives","volume":"52","author":"Wong","year":"2009","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818315219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818315219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:40:19Z","timestamp":1565210419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818315219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":21,"alternative-id":["S0045206818315219"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.01.039","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}